rediff.com
e.g. Tata motors, Reliance MF, 500570
Vista Pharmaceuticals Ltd. - Research Center
524711 VISTAPH Group (Z) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Balance sheet
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Sources of funds
Owner's fund
Equity share capital 7.51 7.36 7.36 6.07 6.07
Share application money - - - - 2.48
Preference share capital - - - - -
Reserves & surplus 29.20 28.09 25.49 23.57 27.25
Loan funds
Secured loans 9.96 12.55 14.98 15.47 11.17
Unsecured loans - - - - -
Total 46.67 48.00 47.82 45.11 46.97
Uses of funds
Fixed assets
Gross block 26.76 25.74 25.72 25.72 24.24
Less : revaluation reserve - - - - -
Less : accumulated depreciation 7.02 6.41 5.79 5.06 3.71
Net block 19.74 19.33 19.93 20.66 20.52
Capital work-in-progress 9.33 9.08 9.08 8.78 8.54
Investments 0.02 0.03 0.04 0.02 0.03
Net current assets
Current assets, loans & advances 26.95 27.14 21.80 21.66 23.66
Less : current liabilities & provisions 9.36 7.59 3.03 6.01 5.79
Total net current assets 17.58 19.56 18.77 15.65 17.87
Miscellaneous expenses not written - - - - -
Total 46.67 48.00 47.82 45.11 46.97
Notes:
Book value of unquoted investments - 0.03 0.04 0.02 -
Market value of quoted investments 0.02 - - - -
Contingent liabilities - - - - 3.99
Number of equity sharesoutstanding (Lacs) 375.57 367.94 367.94 303.65 303.65
Close
Add Vista Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Vista Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close